logo
Sun Pharma launches Leqselvi in US after patent settlement with Incyte Corp

Sun Pharma launches Leqselvi in US after patent settlement with Incyte Corp

Sun Pharmaceuticals on Monday announced the launch of hair loss drug Leqselvi (deuruxolitinib) in the United States (US) market for the treatment of alopecia areata, a condition in which the immune system attacks hair follicles, leading to hair loss on the scalp as well as other parts of the body.
The announcement came after the Mumbai-based pharma major inked a settlement pact with US-based Incyte Corporation regarding the hair loss drug. Incyte had earlier accused Sun Pharma of patent infringement.
Under the terms of the agreement, the parties will seek dismissal of the pending Leqselvi litigation in the United States District Court for the District of New Jersey.
'Incyte has also granted Sun a limited and non-exclusive licence to US patent numbers 9,662,335 and certain other related patents with respect to oral deuruxolitinib for certain agreed-upon non-haematology-oncology indications including alopecia areata, in the US,' the company said in a regulatory filing on the exchanges.
The Mumbai-based pharma major will also pay Incyte an undisclosed upfront amount, plus ongoing royalty payments until the expiry of the patents, in exchange for the settlement and licence.
Deuruxolitinib is expected to go off-patent in the financial year 2025–26 (FY26).
The launch adds Leqselvi to Sun Pharma's innovative therapies portfolio, which saw sales of $1,216 million in FY25, according to Sun Pharma's investor presentation for the year.
According to a Reuters report, Shrikant Akolkar, analyst at Nuvama Institutional Equities, said the drug could generate up to $400 million in sales by FY30, with peak sales potential of $900 million, and boost growth in Sun Pharma's key US market.
Commenting on the launch, Sun Pharma America CEO Richard Ascroft said the launch of Leqselvi in the US brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them.
'As a company committed to launching new therapeutic options which address the unmet needs of patients, adding Leqselvi to our dermatology portfolio represents a key milestone for the business and an important advancement for the alopecia areata community,' he added.
The announcement was made post market hours. On Monday, Sun Pharma's share rose marginally by 0.57 per cent, ending the day's trade at ₹1,682.05 apiece on the Bombay Stock Exchange (BSE).
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WeWork India gets SEBI nod to launch IPO, promoters to sell shares to monetise investments
WeWork India gets SEBI nod to launch IPO, promoters to sell shares to monetise investments

Hindustan Times

time6 minutes ago

  • Hindustan Times

WeWork India gets SEBI nod to launch IPO, promoters to sell shares to monetise investments

New Delhi, Jul 15 (PTI) Co-working major WeWork India has received market regulator Sebi's go-ahead to launch its Initial Public Offering (IPO), enabling the promoters to monetise their investments amid record demand for office spaces across the top seven cities. Co-working major WeWork India has received market regulator Sebi's go-ahead to launch its Initial Public Offering (IPO), enabling the promoters to monetise their investments amid record demand for office spaces across the top seven cities. (Picture for representational purposes only)(Pixabay) Bengaluru-based WeWork India Management Ltd, which filed its Draft Red Herring Prospectus (DRHP) in February, obtained observations from the markets regulator on July 8, an update with the SEBI showed on Tuesday. Established in 2017, WeWork India is promoted by Bengaluru-based real estate company Embassy Group. It has the exclusive license of the 'WeWork' brand in India. Also Read: Incuspaze acquires Pune's Trios to expand coworking biz, targets ₹350-400 crore During the 2023-24 fiscal, WeWork India posted a net loss of ₹135.83 crore over a total income of ₹1,737.16 crore. The company, however, posted a profit of ₹174.13 crore in the first six months of the 2024-25 fiscal. Total income stood at ₹960.76 crore during the April-September period of the 2024-25 financial year. In WeWork India, Embassy Group has around 76.21 per cent stake while WeWork Global owns 23.45 per cent. As per the DRHP, the proposed IPO is entirely an Offer for Sale (OFS) of up to 4.37 crore equity shares. Promoter group firm Embassy Buildcon LLP and investor 1 Ariel Way Tenant Ltd (part of WeWork Global) will offload shares. Through the OFS, Embassy Buildcon LLP will sell up to 33,458,659 equity shares, while 1 Ariel Way Tenant Ltd up to 10,295,293 shares. Since it is an OFS, WeWork India will not receive any proceeds from the IPO. On Monday, Smartworks Coworking Spaces Ltd's ₹583 crore IPO was subscribed 13.45 times. Awfis and EFC (I) Ltd are already listed on the stock exchanges. Co-working operators are tapping capital markets to raise funds for expansion amid rising demand for both conventional and flexible managed workspaces. In its draft papers, WeWork India stated that the object of the offer is to achieve the benefits of listing the equity shares on the stock exchanges. "Our company expects that listing of the equity shares will enhance our visibility and brand and provide liquidity to its existing shareholders. The listing will also provide a public market for the equity shares in India," WeWork India had said in the DRHP. Also Read: Mumbai real estate: WeWork India leases 1.26 lakh sq ft of commercial space in Powai for ₹1.38 crore monthly rent WeWork Global had in June 2021 invested USD 100 million in WeWork India. In January this year, the company raised ₹500 crore through a rights issue, mainly to reduce debt and achieve further growth. WeWork India provides flexible, high-quality workspaces to customers, which include companies of all sizes as well as individuals. It primarily leases Grade A office space from leading developers across Tier 1 cities and designs, builds, and operates them as flexible workspaces. Its portfolio comprises 77 lakh square feet of area, of which 70 lakh square feet is already operational. The operational desk capacity has reached 1.03 lakh. The company has a presence in Bengaluru, Mumbai, Pune, Hyderabad, Gurugram, Noida, Delhi, and Chennai. It has more than 500 employees.

Hyderabad Investors Pour Rs 310 Cr into Tata Arbitrage Fund in 3 months as Market Volatility Shifts Strategy
Hyderabad Investors Pour Rs 310 Cr into Tata Arbitrage Fund in 3 months as Market Volatility Shifts Strategy

Hans India

time12 minutes ago

  • Hans India

Hyderabad Investors Pour Rs 310 Cr into Tata Arbitrage Fund in 3 months as Market Volatility Shifts Strategy

Arbitrage Funds are gaining traction as an investment option amid equity market volatility, particularly for those seeking low risk investment opportunity. By capitalising on price differences between the cash and futures markets, these funds seek to perform better in turbulent conditions, giving fund managers greater scope for intra-month trading opportunities. "In the current environment, arbitrage funds are uniquely positioned to capture the potential benefits of market volatility while shielding investors from direct equity risks. Elevated roll spreads and sustained volatility have enabled arbitrage funds to deliver reasonable returns, even as traditional income avenues have become less attractive. For investors seeking equity tax returns, arbitrage funds offer a suitable proposition," said Sailesh Jain, Fund Manager, Tata Asset Management. According to data from the Association of Mutual Funds in India (AMFI), arbitrage funds attracted Rs 43,077 crore between April and June 2025, surpassing inflows into other hybrid and equity categories. This surge underscores investor preference for instruments that can deliver relatively reasonable returns while minimising equity risk during periods of heightened uncertainty. However, profit is not guaranteed. Reflecting the broader industry trend, the Tata Arbitrage Fund too, saw inflows of Rs 5,217 crore between April and June 2025, with Rs 310 crore coming from Hyderabad. The fund had assets under management of Rs 14,274 crore as of June 30, 2025. The environment is especially conducive for arbitrage strategies, as elevated volatility and strong roll spreads have opened potential return opportunities. The Reserve Bank of India's recent easing measures—cutting the repo rate by 50 basis points and the Cash Reserve Ratio by 100 basis points—has further boosted the appeal of arbitrage funds over traditional fixed income avenues. The upcoming corporate earnings and a positive monsoon outlook are also expected to lift market sentiment. As global and domestic uncertainties continue to cloud market outlook, arbitrage funds are a choice for investors to help them navigate choppy waters. With interest rates on a downward trend and savings account returns declining, traditional fixed-income options have become relatively less attractive in terms of returns. At the same time, factors such as the anticipated Indo-US trade deal, tariff negotiations, and ongoing geopolitical tensions are keeping the market volatility elevated. Although the US dollar index remains subdued for now, any spike in global risk aversion may trigger fresh market swings. In this backdrop, arbitrage funds seek to offer investors a low-risk way to capitalise on volatility without direct equity exposure.

Oracle to invest $3 billion in AI, cloud expansion in Germany, Netherlands
Oracle to invest $3 billion in AI, cloud expansion in Germany, Netherlands

Time of India

time18 minutes ago

  • Time of India

Oracle to invest $3 billion in AI, cloud expansion in Germany, Netherlands

Oracle will invest $3 billion in Germany and the Netherlands over the next five years to bolster its infrastructure powering artificial intelligence and cloud offerings in the European market, the company said on Tuesday. The Austin, Texas-based company joins a growing list of technology firms that have pledged tens of billions of dollars to meet robust cloud computing demand as businesses increasingly deploy AI workloads. Last year, Amazon said it would invest 10 billion euros in Germany, bringing its total planned investments in the European country to 17.8 billion euros. Together, big tech companies are expected to spend $320 billion on AI this year. On Monday, Meta CEO Mark Zuckerberg said the social media giant would spend hundreds of billions of dollars to build several massive AI data centers. Demand has been growing for the cloud and AI services offered by firms including Oracle, Microsoft and Google because they can replace or outperform software created by traditional IT firms, some analysts say. Oracle would spend $2 billion in Germany and $1 billion in the Netherlands, the company said in separate statements. Its shares rose 2% in trading before the bell. They have risen nearly 38% so far this year. The company expects its capital spending to surpass $25 billion in fiscal 2026, with the bulk of the expenditure committed to data-center infrastructure, including for AI. "As we bring more capacity online, our revenue and profit growth will further accelerate," Oracle CEO Safra Catz said in June. Oracle has secured a deal with an undisclosed client that is expected to generate over $30 billion in annual revenue for the company starting in fiscal year 2028, according to a regulatory filing last month.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store